Physician profile
Barry Waldman
NPI 1700875655
$30,075.92
in general payments reported to CMS, 2019-2025
24 companies · $2,042 in 2025
The $2,042 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,115 · 2020: $1,873 · 2021: $3,351 · 2022: $11K · 2023: $1,104 · 2024: $8,589 · 2025: $2,042.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Food and Beverage: $878.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,856.00 |
| Food and Beverage | $878.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, Lp | $18,571.94 | 2019-2025 | Djo Surgical |
| Medacta USA, INC. | $5,515.52 | 2020-2024 | |
| Depuy Synthes Products, INC. | $1,512.50 | 2024 | |
| Pacira Therapeutics, INC. | $1,440.05 | 2019-2020 | |
| Conformis, INC. | $1,287.14 | 2019-2022 | |
| Hikma Pharmaceuticals USA | $343.50 | 2024 | Combogesic IV |
| Deroyal Industries, INC. | $240.00 | 2024 | Flex Npwt Single Use System |
| Stryker Corporation | $215.86 | 2019-2020 | |
| Depuy Synthes Sales INC. | $158.17 | 2023-2025 | Velys |
| Abbott Laboratories | $125.57 | 2023 | Proclaim |
| Medical Device Business Services, INC. | $125.00 | 2024 | Attune |
| Supreme Orthopedic Systems, LLC | $118.01 | 2024 | |
| Zimmer Biomet Holdings, INC. | $111.62 | 2023 | Persona |
| Ferring Pharmaceuticals INC. | $70.96 | 2020 | |
| Amgen INC. | $55.40 | 2019-2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $36.41 | 2019-2021 | |
| Si-Bone, INC. | $31.40 | 2019 | |
| Sanofi-Aventis U.S. LLC | $22.12 | 2019 | |
| Fidia Pharma USA INC. | $20.63 | 2020 | |
| Smith+Nephew, INC. | $18.35 | 2021 | |
| Dynasplint Systems INC. | $16.71 | 2019 | |
| Convatec INC. | $15.62 | 2019 | |
| Electronic Waveform Lab, INC. | $12.03 | 2019 | |
| Heraeus Medical, LLC. | $11.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Waldman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.